• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药多糖与肠道微生物群之间的相互作用:难以捉摸的“多糖-键-细菌-酶”等式

Interplay between traditional Chinese medicine polysaccharides and gut microbiota: The elusive "polysaccharides-bond-bacteria-enzyme" equation.

作者信息

Rong XinQian, Shen CanTing, Shu QingLong

机构信息

Jiangxi University of Chinese Medicine, Nanchang, China.

出版信息

Phytother Res. 2024 Sep;38(9):4695-4715. doi: 10.1002/ptr.8284. Epub 2024 Aug 9.

DOI:10.1002/ptr.8284
PMID:39120443
Abstract

Polysaccharides are one of the most important components of traditional Chinese medicine (TCM) and have been extensively studied for their immunomodulatory properties. The functions and effects of TCM polysaccharides are closely related to the gut microbiota, making the study of their interaction a hot topic in the field of TCM metabolism. This review follows two main inquiries: first, how the gut microbiota breaks down TCM polysaccharides to produce bioactive metabolites; and second, how TCM polysaccharides reshape the gut microbiota as a carbon source. Understanding the interaction mechanism involves a challenging equation of the structural association of TCM polysaccharides with the metabolic activities of the microbiota. This review has meticulously searched, partially organized literature spanning the past decade, that delves into the interaction mechanism between TCM polysaccharides and gut microbiota. It also gives an overview of the complex factors of the elusive "polysaccharides-bond-bacteria-enzyme" equation: the complexity of polysaccharide structures, the diversity of glycosidic bond types, the communal nature of metabolizing microbiota, the enzymes involved in functional degradation by microbiota, and the hierarchical roles of polysaccharide utilization locus and gram-positive PULs. Finally, this review aims to facilitate discussion among peers in the field of TCM microbiota and offers prospects for research in related fields, paving the way for pharmacological studies on TCM polysaccharides and gut microbiota therapeutics, and providing a reference point for further clinical research.

摘要

多糖是中药最重要的成分之一,其免疫调节特性已得到广泛研究。中药多糖的功能和作用与肠道微生物群密切相关,这使得对它们相互作用的研究成为中药代谢领域的一个热门话题。本综述主要探讨两个问题:第一,肠道微生物群如何分解中药多糖以产生生物活性代谢物;第二,中药多糖如何作为碳源重塑肠道微生物群。理解相互作用机制涉及到一个具有挑战性的等式,即中药多糖的结构与微生物群代谢活动之间的关联。本综述精心检索、部分整理了过去十年的文献,这些文献深入探讨了中药多糖与肠道微生物群之间的相互作用机制。它还概述了难以捉摸的“多糖-键-细菌-酶”等式的复杂因素:多糖结构的复杂性、糖苷键类型的多样性、代谢微生物群的共同性质、微生物群参与功能降解的酶,以及多糖利用位点和革兰氏阳性菌多糖利用位点的层级作用。最后,本综述旨在促进中药微生物群领域同行之间的讨论,并为相关领域的研究提供前景,为中药多糖和肠道微生物群治疗的药理学研究铺平道路,并为进一步的临床研究提供参考点。

相似文献

1
Interplay between traditional Chinese medicine polysaccharides and gut microbiota: The elusive "polysaccharides-bond-bacteria-enzyme" equation.中药多糖与肠道微生物群之间的相互作用:难以捉摸的“多糖-键-细菌-酶”等式
Phytother Res. 2024 Sep;38(9):4695-4715. doi: 10.1002/ptr.8284. Epub 2024 Aug 9.
2
Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.中药多糖与肠道微生物群的相互作用:理解中药的新视角。
Phytother Res. 2022 Nov;36(11):4125-4138. doi: 10.1002/ptr.7607. Epub 2022 Sep 13.
3
The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review.肠道微生物群与中药生物活性成分的相互作用:综述。
Pharmacol Res. 2020 Jul;157:104824. doi: 10.1016/j.phrs.2020.104824. Epub 2020 Apr 25.
4
Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.肠道微生物群:中医药治疗抑郁症的新靶点。
J Ethnopharmacol. 2023 Mar 1;303:116038. doi: 10.1016/j.jep.2022.116038. Epub 2022 Dec 15.
5
The science behind TCM and Gut microbiota interaction-their combinatorial approach holds promising therapeutic applications.中医与肠道微生物群相互作用的科学——它们的组合方法具有有前途的治疗应用。
Front Cell Infect Microbiol. 2022 Sep 13;12:875513. doi: 10.3389/fcimb.2022.875513. eCollection 2022.
6
Gut microbiota, a new frontier to understand traditional Chinese medicines.肠道微生物群,理解中药的新前沿。
Pharmacol Res. 2019 Apr;142:176-191. doi: 10.1016/j.phrs.2019.02.024. Epub 2019 Feb 25.
7
Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.中药调节肠道微生物群代谢物介导的脂质代谢机制。
J Ethnopharmacol. 2021 Oct 5;278:114207. doi: 10.1016/j.jep.2021.114207. Epub 2021 May 14.
8
The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.肠道微生物群与中医(TCM)性质理论的关联:以寒、甜味中药为例。
J Ethnopharmacol. 2023 Apr 24;306:116167. doi: 10.1016/j.jep.2023.116167. Epub 2023 Jan 11.
9
The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.肠道微生物群与中医药:癌症的新临床前沿。
Curr Drug Targets. 2021;22(11):1222-1231. doi: 10.2174/1389450122666210412141304.
10
Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota.中药修复肠道屏障:肠道微生物群的作用。
Front Cell Infect Microbiol. 2024 Jul 4;14:1389925. doi: 10.3389/fcimb.2024.1389925. eCollection 2024.

引用本文的文献

1
Therapeutic mechanisms of polysaccharides in the management of rheumatoid arthritis: a comprehensive review.多糖在类风湿关节炎治疗中的作用机制:综述
Front Immunol. 2025 Jul 1;16:1608909. doi: 10.3389/fimmu.2025.1608909. eCollection 2025.
2
Synergistic gut microbiome-mediated degradation of polysaccharides and polysaccharides into butyric acid: a metatranscriptomic analysis.肠道微生物群协同介导多糖降解为丁酸的宏转录组分析
Microbiol Spectr. 2025 Jul;13(7):e0303924. doi: 10.1128/spectrum.03039-24. Epub 2025 May 27.
3
Effects of Dietary Yeast β-1,3/1,6-D-Glucan on Immunomodulation in RAW 264.7 Cells and Methotrexate-Treated Rat Models.
酵母β-1,3/1,6-葡聚糖对 RAW264.7 细胞和甲氨蝶呤处理大鼠模型的免疫调节作用。
Int J Mol Sci. 2024 Oct 14;25(20):11020. doi: 10.3390/ijms252011020.